Tucker Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Tucker Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-28	Closed	-$6.94K	–	228
2026 Q2	$6.94K	Sell	28 -452	-94%	-$97.4K	﹤0.01%	361
2026 Q1	$96.4K	Buy	480 +63	+15%	+$13K	0.03%	185
2025 Q4	$86.1K	Buy	417 +142	+52%	+$28.4K	0.03%	220
2025 Q3	$49.3K	Sell	275 -14	-5%	-$2.38K	0.01%	181
2025 Q2	$46.6K	Buy	289 +213	+280%	+$33.9K	0.01%	167
2025 Q1	$12.9K	Buy	76 +34	+81%	+$5.9K	﹤0.01%	220
2024 Q4	$6.98K	Buy	+42	New	+$7.18K	﹤0.01%	884
2021 Q3	–	Sell	-3	Closed	-$518	–	385
2021 Q2	$518	Sell	3 -2	-40%	-$330	﹤0.01%	338
2021 Q1	$803	Hold	5	–	–	﹤0.01%	316
2020 Q4	$840	Buy	+5	New	+$811	﹤0.01%	342

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Berger Financial Group Plymouth, Minnesota $2.01B AUM 15.82% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return

Tucker Asset Management's FBT Position: Q3 2026 in Review

Tucker Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 28 shares — an estimated $6.94K sold.

Tucker Asset Management first reported a position in FBT in Q4 2020 and held it in 10 quarters. The position peaked at $96.4K in Q1 2026. 311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Tucker Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
Tucker Asset Management sold 28 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $6.94K.
Tucker Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and held it in 10 quarters.
Tucker Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $96.4K in Q1 2026.
311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Tucker Asset Management's 13F filing for Q3 2026, filed 29 Oct 2026.